0001209191-12-046196.txt : 20120919
0001209191-12-046196.hdr.sgml : 20120919
20120919170546
ACCESSION NUMBER: 0001209191-12-046196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120917
FILED AS OF DATE: 20120919
DATE AS OF CHANGE: 20120919
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 121100304
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-09-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2012-09-17
4
M
0
6500
16.32
A
138816
D
Common Stock
2012-09-17
4
S
0
6500
57.52
D
132316
D
Common Stock
4647
I
401(k)
Common Stock
15920
I
Common Stock held in trust.
Employee Stock Option Grant (right to buy)
16.32
2012-09-17
4
M
0
6500
0.00
D
2013-07-14
Common Stock
6500
16300
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $57.52 (range $57.30 to $57.90).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Common stock held in grantor retained annuity trusts.
Fully vested.
Valerie L. Andrews, Attorney-In-Fact
2012-09-19